Noncanonical functions of EZH2 in triple-negative breast cancers

被引：0
|
作者：
Anwar, Talha [1 ]
Moore, Heather [1 ]
Bergholtz, Sarah [1 ]
Kleer, Celina [1 ]
机构：
[1] Univ Michigan, Sch Med, Ann Arbor, MI USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-4790
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4790
引用
收藏
页数：1
相关论文
共 50 条
  • [31] EZH2 inhibition re-sensitizes drug resistant triple-negative breast cancer PDX models to Eribulin
    Bozek, Kathryn
    Darini, Cedric
    Lan, Cathy
    Buchanan, Marguerite
    Chabot, Catherine
    Lafleur, Josiane
    Guay, Juliet
    Filosa, Eva
    Aguilar-Mahecha, Adriana
    Basik, Mark
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [32] CDK2-mediated site-specific phosphorylation of EZH2 drives and maintains triple-negative breast cancer
    Nie, Lei
    Wei, Yongkun
    Zhang, Fei
    Hsu, Yi-Hsin
    Chan, Li-Chuan
    Xia, Weiya
    Ke, Baozhen
    Zhu, Cihui
    Deng, Rong
    Tang, Jun
    Yao, Jun
    Chu, Yu-Yi
    Zhao, Xixi
    Han, Ye
    Hou, Junwei
    Huo, Longfei
    Ko, How-Wen
    Lin, Wan-Chi
    Yamaguchi, Hirohito
    Hsu, Jung-Mao
    Yang, Yi
    Pan, Dean N.
    Hsu, Jennifer L.
    Kleer, Celina G.
    Davidson, Nancy E.
    Hortobagyi, Gabriel N.
    Hung, Mien-Chie
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [33] The noncanonical role of EZH2 in cancer
    Huang, Jinhua
    Gou, Hongwei
    Yao, Jia
    Yi, Kaining
    Jin, Zhigang
    Matsuoka, Masao
    Zhao, Tiejun
    CANCER SCIENCE, 2021, 112 (04) : 1376 - 1382
  • [34] Triple Negative Breast Cancer: prognosis of triple-negative breast cancers and non-triple-negative breast cancers in a large registry of certified breast units
    Kern, P.
    Rezai, M.
    CANCER RESEARCH, 2012, 72
  • [35] Targeting triple negative breast cancer with a VHL recruiting EZH2 protein degrader
    Dale, Brandon
    Anderson, Chris
    Park, Kwang-su
    Kaniskan, H. Umit
    Yu, Xufen
    Jin, Jian
    CANCER RESEARCH, 2022, 82 (12)
  • [36] CRISPR/Cas9-mediated EZH2 knockout suppresses the proliferation and migration of triple-negative breast cancer cells
    Mao, Qiqi
    Wu, Peibin
    Li, Haochen
    Fu, Xiaolan
    Gao, Xuechen
    Yang, Lei
    ONCOLOGY LETTERS, 2023, 26 (02)
  • [37] Curcumin inhibits the growth of triple-negative breast cancer cells by silencing EZH2 and restoring DLC1 expression
    Zhou, Xueliang
    Jiao, Dechao
    Dou, Mengmeng
    Zhang, Weijie
    Lv, Liying
    Chen, Jianjian
    Li, Lifeng
    Wang, Liuxing
    Han, Xinwei
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (18) : 10648 - 10662
  • [38] Simultaneous inhibition of EZH2 and activation of dopamine D1 in an isotropic triple-negative breast cancer microgel model
    Rima, Xilal Y.
    Sarathy, Gautham
    Rizzotto, Lara
    Kulkarni, Anagh
    Palmieri, Dario
    Kararoudi, Meisam Naeimi
    Reategui, Eduardo
    Ramaswamy, Bhuvaneswari
    Shankar, Eswar
    CANCER RESEARCH, 2023, 83 (07)
  • [39] MiR-340 Inhibits Triple-Negative Breast Cancer Progression by Reversing EZH2 Mediated miRNAs Dysregulated Expressions
    Shi, Zhendong
    Li, Yang
    Qian, Xiaomin
    Hu, Yunhui
    Liu, Jingjing
    Zhang, Sheng
    Zhang, Jin
    JOURNAL OF CANCER, 2017, 8 (15): : 3037 - 3048
  • [40] The possible role of EZH2 and DNMT1 polymorphisms in sporadic triple-negative breast carcinoma in southern Chinese females
    Tao, Ran
    Chen, Zekun
    Wu, Pingping
    Liu, Cuicui
    Peng, You
    Zhao, Weiwei
    Hu, Chaohui
    Feng, Jing
    TUMOR BIOLOGY, 2015, 36 (12) : 9849 - 9855
12345